Keywords: Visualization, Hyperpolarized MR (Gas), 129Xe MRI, Lung cancer, immunotherapy, ferroptosis
Motivation: The evaluation of lung cancer immunotherapy progress using non-invasive methods is challenging. Also, multiple scans of CT during the treatment period expose patients to more radiation.
Goal(s): To confirm 129Xe MRI is a potentially robust technology for monitoring immunotherapy effects.
Approach: Fe3O4-based nanoprobe that could induce ferroptosis of tumor cells was prepared for immunotherapy of lung metastatic cancer combined with α-PD-L1, finally the immunotherapy effect was evaluated via 129Xe MRI.
Results: The 129Xe MRI displayed a complete ventilatory image of the lung in the probe plus α-PD-L1 group while severe ventilation deficiency was observed in the control group.
Impact: The 129Xe MRI results of the lung showed significant differences in ventilation defects among different treatment groups, revealing the excellent tumor immunotherapy efficiency of nanoprobe-mediated immunotherapy, which represents a potential protocol for the evaluation of immunotherapy against tumors.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords